Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedIntroducing a government-funded status notice and a version upgrade to v3.2.0, replacing v3.0.2.SummaryDifference3%
- Check21 days agoChange DetectedCore content removing MedlinePlus drug safety topics and related MeSH terms; overall narrowing of drug-safety coverage.SummaryDifference0.7%
- Check28 days agoChange DetectedMinor formatting/localization update: adds a Mexican spelling/locale variant (México, Mexico, 03100) and removes the generic variant (Mexico, Mexico, 03100) and the Back to Top link.SummaryDifference0.2%
- Check35 days agoChange DetectedRevision updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2 and a Back to Top link was added. The old revision tag was removed and there are no changes to core content, pricing, stock, or names.SummaryDifference0.2%
- Check42 days agoChange DetectedThe page has updated the spelling of the location from 'México' to 'Mexico' and has changed the version number from 'v3.0.0' to 'v3.0.0-post.1-g752effb-HEAD'.SummaryDifference0.1%
- Check49 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility locations across various countries, while also removing outdated location references and certain medical topics. Notably, the facility names and locations have been clarified and expanded.SummaryDifference16%
Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.